|
Proto-Oncogene Protein c-ets-1
|
D050784 |
[An ets proto-oncogene protein expressed primarily in adult LYMPHOID TISSUE; BRAIN; and VASCULAR ENDOTHELIAL CELLS.
] |
|
Post and Core Technique
|
D011176 |
[Use of a metal casting, usually with a post in the pulp or root canal, designed to support and retain an artificial crown.
] |
|
Postal Service
|
D011177 |
[The functions and activities carried out by the U.S. Postal Service, foreign postal services, and private postal services such as Federal Express.
] |
|
Cryoanesthesia
|
D050785 |
[ANESTHESIA achieved by lowering either BODY TEMPERATURE (core cooling) or SKIN TEMPERATURE (external cooling).
] |
|
Gastric Hypothermia
|
D050786 |
[A method of lowering core BODY TEMPERATURE by filling the STOMACH with chilled fluids.
] |
|
Postgastrectomy Syndromes
|
D011178 |
[Sequelae of gastrectomy from the second week after operation on. Include recurrent or anastomotic ulcer, postprandial syndromes (DUMPING SYNDROME and late postprandial hypoglycemia), disordered bowel action, and nutritional deficiencies.
] |
|
Proto-Oncogene Protein c-ets-2
|
D050787 |
[A ubiquitously expressed ets proto-oncogene protein that may play a role in regulation of CELL PROLIFERATION and CELL DIFFERENTIATION.
] |
|
STAT5 Transcription Factor
|
D050799 |
[A signal transducer and activator of transcription that mediates cellular responses to a variety of CYTOKINES. Stat5 activation is associated with transcription of CELL CYCLE regulators such as CYCLIN KINASE INHIBITOR P21 and anti-apoptotic genes such as BCL-2 GENES. Stat5 is constitutively activated in many patients with acute MYELOID LEUKEMIA.
] |
|
Potassium Cyanide
|
D011190 |
[A highly poisonous compound that is an inhibitor of many metabolic processes, but has been shown to be an especially potent inhibitor of heme enzymes and hemeproteins. It is used in many industrial processes.
] |
|
PSMG2 protein, human
|
C456359 |
|
|
Potassium Deficiency
|
D011191 |
[A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed)
] |
|
Potassium Dichromate
|
D011192 |
[Chromic acid (H2Cr2O7), dipotassium salt. A compound having bright orange-red crystals and used in dyeing, staining, tanning leather, as bleach, oxidizer, depolarizer for dry cells, etc. Medically it has been used externally as an astringent, antiseptic, and caustic. When taken internally, it is a corrosive poison.
] |
|
Potassium Iodide
|
D011193 |
[An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
] |
|
(d-Ala(5))-(2-8)-LPK, leucopyrokinin analog
|
C495937 |
|
|
2,4,6-triisopropylbenzenetellurinic acid
|
C495938 |
|
|
tenuecyclamide A
|
C495939 |
|
|
4'-hydroxy-6-nitroflavylium
|
C495930 |
|
|
Jelleine I
|
C495931 |
|
|
Jelleine II
|
C495932 |
|
|
Jelleine III
|
C495933 |
|
